Rigel Pharmaceuticals
RIGL
RIGL
127 hedge funds and large institutions have $407M invested in Rigel Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 45 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
0.3% less ownership
Funds ownership: 9.31% → 9% (-0.3%)
3% less funds holding
Funds holding: 131 → 127 (-4)
Holders
127
Holding in Top 10
1
Calls
$835K
Puts
$362K
Top Buyers
| 1 | +$13.1M | |
| 2 | +$2.47M | |
| 3 | +$1.72M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.49M |
| 5 |
JP Morgan Chase
New York
|
+$1.35M |
Top Sellers
| 1 | -$6.37M | |
| 2 | -$4.56M | |
| 3 | -$4.14M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.19M |